Brest, France

Claude Ferec



 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Plougastel-Deaoulas, FR (2012)
  • Brest, FR (2010 - 2022)

Company Filing History:


Years Active: 2010-2022

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Claude Ferec: Innovator in Pharmaceutical Research

Introduction

Claude Ferec is a notable inventor based in Brest, France. He has made significant contributions to the field of pharmaceutical research, particularly in the treatment of diseases associated with reduced CFTR function. With a total of 3 patents to his name, Ferec's work is paving the way for innovative therapeutic approaches.

Latest Patents

Ferec's latest patents include methods and pharmaceutical compositions aimed at treating diseases linked to reduced CFTR function. One of his key inventions involves the use of a site-1 protease (S1P) inhibitor, such as PF-429242, which has shown promise in partially restoring both the membrane localization and function of F508del-CFTR. This method offers a potential therapeutic approach based on the regulation of the unfolded protein response (UPR). Another significant patent involves analogue compounds of archaebacterial membrane lipids and liposomal compounds, which are designed to enhance the efficacy of treatments.

Career Highlights

Throughout his career, Claude Ferec has worked with esteemed institutions such as Université de Bretagne Occidentale and Institut National de la Santé et de la Recherche Médicale. His research has focused on understanding the mechanisms behind CFTR repression and developing innovative solutions to combat related diseases.

Collaborations

Ferec has collaborated with notable colleagues, including Tristan Montier and Pascal Delepine. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Claude Ferec's innovative work in pharmaceutical research highlights his commitment to improving treatments for diseases associated with CFTR function. His contributions are significant in the ongoing quest for effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…